Genentech announced positive results from the phase III DBRPCT ALLEGORY trial showin safety & efficacy of obinutuzumab in ~300 SLE pts on SOC. Results have yet to be presented publicly. https://t.co/4hoT9dBtPq
Links:
Positive Phase III Data for Genentech’s Gazyva Show Significant Reduction in Di…
https://buff.ly/Jibu0Vh
11-11-2025
